Analgesics News
Drugs
> AnalgesicsAnalgesics News is an EIN News Service for health professionals. Constantly updated news and information about health.
- What Is A Dental Abscess? What Causes Dental Abscesses? 7 Nov 2009 08:37 GMT
... tooth root." A dental abscess usually requires treatment; otherwise it can worsen and result in ... treat an abscess, but he/she may prescribe medication and advise on self-care and pain management, ... out). OTC (over-the-counter, no prescription required) painkillers (analgesics) may help reduce the pain while the ...
- Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference / Proof-of-Concept Data at 12th International Conference on the Mechanisms and Treatme 5 Nov 2009 00:34 GMT
... 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, to be held November ... Capsaicin Induced Hyperalgesia Model." NGX426 is a prodrug of Raptor's parenterally administered product candidate tezampanel. ... subcutaneously and intravenously tezampanel demonstrated statistically significant analgesic effect in five Phase II trials. The ...
- Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Ora 5 Nov 2009 11:16 GMT
... 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, to be held November ... Capsaicin Induced Hyperalgesia Model." NGX426 is a prodrug of Raptor's parenterally administered product candidate tezampanel. ... subcutaneously and intravenously tezampanel demonstrated statistically significant analgesic effect in five Phase II trials. The ...
- Cumberland Pharmaceuticals and Phebra Pty Ltd. Sign Exclusive Agreement for Commercialization of Caldolor in Australia and New Zealand 2 Nov 2009 21:36 GMT
... setting. Cumberland Pharmaceuticals received U.S. Food and Drug Administration approval for Caldolor in June 2009. ... in Australia and New Zealand for the treatment of pain and fever, featuring analgesic, antipyretic and anti-inflammatory properties. More than 10 ...
- Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neur 5 Nov 2009 00:33 GMT
... Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference NOVATO, Calif., Nov. ... 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, to be held November ... Capsaicin Induced Hyperalgesia Model." NGX426 is a prodrug of Raptor's parenterally administered product candidate tezampanel. ...
- Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference 5 Nov 2009 00:30 GMT
... Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference Proof-of-Concept Data at ... 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain NOVATO, Calif., Nov. 4 ... Capsaicin Induced Hyperalgesia Model." NGX426 is a prodrug of Raptor's parenterally administered product candidate tezampanel. ...
- Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference (CNW) 5 Nov 2009 00:30 GMT
... Capsaicin Induced Hyperalgesia Model." NGX426 is a prodrug of Raptor's parenterally administered product candidate tezampanel. ... subcutaneously and intravenously tezampanel demonstrated statistically significant analgesic effect in five Phase II trials. The ... NGX426 or placebo in each of three treatment periods. Pain was induced by injecting 250 ...
- Raptor Pharmaceutical to present oral AMPA-kainate antagonist data at the neuropathic pain conference 5 Nov 2009 06:42 GMT
... 12th International Conference on the Mechanisms and Treatment of Neuropathic Pain, to be held November ... Capsaicin Induced Hyperalgesia Model." NGX426 is a prodrug of Raptor's parenterally administered product candidate tezampanel. ... subcutaneously and intravenously tezampanel demonstrated statistically significant analgesic effect in five Phase II trials. The ...
- Covidien Receives FDA Approval For Oral Transmucosal Fentanyl Citrate Product 2 Nov 2009 12:34 GMT
... Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New ... Class II controlled substance, is an opioid analgesic indicated only for the management of breakthrough ... this FDA approval and to introduce this treatment option to meet patients' needs." Covidien expects ...
- BUYINS.NET: ZGEN, INWK, SCR, LNY, ELMG, WPC Expected To Be Higher After Earnings Releases on Thursday 3 Nov 2009 09:37 GMT
... and commercialization of therapeutic proteins for the treatment of human diseases, including hemostasis, inflammatory and ... diclofenac sodium, an anti-inflammatory pain reliever and analgesic drug to treat rheumatoid arthritis and osteoarthritis under ...
- Global OTC Pharmaceutical Market By Bharatbook.com 5 Nov 2009 09:03 GMT
... major categories of OTC pharmaceuticals, including: • Analgesics – for internal and external uses • ... Dermatology - including antifungal agents and hair-loss treatments • Gastrointestinal drugs - including those for acid-related disorders, laxatives ...
- Doctors urged to prescribe swine flu medicine also to patients not in risk groups 6 Nov 2009 13:13 GMT
... have caught swine flu, and the antiviral drugs are most effective if the patient starts ... necessarily have made her a candidate for treatment with Tamiflu. who have been given the ... not to automatically give the child the analgesic paracetamol if the vaccination is followed by ...
- Mallinckrodt painkiller gets FDA OK 2 Nov 2009 14:56 GMT
... A generic painkiller developed by Covidien’s pharmaceutical subsidiary, Mallinckrodt Inc., has received approval from ... received approval from the U.S. Food and Drug Administration. The Oral Transmucosal Fentanyl Citrate is an ... Oral Transmucosal Fentanyl Citrate is an opiod analgesic designed for cancer patients to place inside ...
- Iranian Scholars Share Avicenna's Medieval Medical Wisdom 2 Nov 2009 09:54 GMT
... ailments, certain mediaeval physicians had a useful medical textbook on hand offering detailed information remarkably ... internal wounds and inflammations and principles of treatments. The authors also highlight both herbal and ... of these herbs contain bioactive compounds with analgesic, antispasmodic, bronchodilatory or antimicrobial activities. For instance, ...
- Bernhard Hampl, Ph.D. Elected to Serve as Executive Chairman of the Board of Directors of Fresenius Kabi Pharmaceuticals Holding, Inc. 3 Nov 2009 01:10 GMT
... SCHAUMBURG, Ill.--(BUSINESS WIRE)-- Fresenius Kabi Pharmaceuticals Holding, Inc., (NASDAQ: ), which acquired APP ... a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. The company offers ... for fluid substitution, blood volume expansion, I.V. drugs and parenteral nutrition, as well as products for ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Healthcare Industry Today
|
a digital news provider
bbc.co.uk:
healthday.com:
reuters.com: